T0	Outcomes 0 8	Efficacy
T1	Outcomes 236 247	blepharitis
T2	Outcomes 374 382	efficacy
T3	Outcomes 1208 1319	eyelid debris, eyelid redness, eyelid swelling, meibomian gland (MG) plugging, and the quality of MG secretion.
T4	Outcomes 1368 1395	overall symptomatic relief.
T5	Outcomes 1501 1525	significant improvements
T6	Outcomes 1529 1575	MG plugging, MG secretions, and eyelid redness
T7	Outcomes 1640 1651	MG plugging
T8	Outcomes 1694 1725	MG secretion returned to normal
T9	Outcomes 1869 1895	overall symptomatic relief
T10	Outcomes 1918 1974	Visual acuity measurements and biomicroscopic evaluation
T11	Outcomes 1984 2008	no ocular safety issues.
T12	Outcomes 2100 2138	significantly greater clinical benefit
T13	Outcomes 2182 2226	signs and symptoms of posterior blepharitis.